Extracorporeal Carbon Dioxide Removal to Avoid Invasive Ventilation During Exacerbations of Chronic Obstructive Pulmonary Disease: VENT-AVOID Trial – A Randomized Clinical Trial
Abhijit Duggal, Nicholas S. Hill(Cornell University), Alexandra G. May(LivaNova (United States)), Daniel Brodie(Johns Hopkins University), Nicholas Barrett(King's College London), Mohamed Saad(King Faisal Specialist Hospital & Research Centre), V. Marco Ranieri(University of Bari Aldo Moro), Laurent Brochard(University of Toronto), Sonal Pannu(Oklahoma City University), Tariq Cheema(Unknown), Steven A. Conrad(University of Florida), Stefano Nava(University of Bologna), Ramiro Saavedra-Romero(Abbott Northwestern Hospital)
American Journal of Respiratory and Critical Care Medicine
January 23, 2024
Cited by 22
Related Papers
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
High-Flow Oxygen through Nasal Cannula in Acute Hypoxemic Respiratory Failure
|New England Journal of Medicine|2015|2.4k
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study
|The Lancet|2020|2.3k
Noninvasive Ventilation for Acute Exacerbations of Chronic Obstructive Pulmonary Disease
|New England Journal of Medicine|1995|2k